# Ursodeoxycholic Acid as Treatment for Polycystic Liver Disease

> **NCT02021110** · PHASE2 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 34 (actual)

## Conditions studied

- Polycystic Liver Disease
- Polycystic Kidney, Autosomal Dominant

## Interventions

- **DRUG:** Ursodeoxycholic Acid

## Key facts

- **NCT ID:** NCT02021110
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2021-09-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02021110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02021110, "Ursodeoxycholic Acid as Treatment for Polycystic Liver Disease". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT02021110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*